Medivolve Announces Q3 2021 Results – Reaches Record Levels of Revenue
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
[vc_row][vc_column]
Medivolve delivered a quarter of strong results, achieving an impressive 575% increase in revenue in growth.
Medivolve Inc. is pleased to announce that it has closed the previously announced private placement of an aggregate of 7,142,857 units at a price per Unit of $0.07 for aggregate gross proceeds to the Company of $500,000.
The Company plans to use the net proceeds from the Offering to expand its operating business, enhance regulatory capital, marketing, and for general corporate purposes.
Proposed Investments Would Provide the Capital to Accelerate the Runway for Growth Across Business Units and Continue Medivolve’s Mission to Deliver Value to Shareholders
Medivolve Expands Footprint with Launch of Mobile Vans Providing Free COVID-19 Testing Services in Las Vegas, Nevada, and surrounding areas.
To support Medivolve’s proactive plans to provide healthcare services beyond the COVID-19 pandemic, hiring of 400+ Doctors, Physician Assistants, Nurse Practitioners, Registered Nurses, and Therapists will be hired within the next 18 months.
Medivolve’s Electronic Health Record Portal Enhances End User Experience Improving Patient Access to Records, Lab Workflow, and Reporting
Medivolve Closes Marbella Pharmacy Deal Supporting Next Phase of Growth in Combining Data-Driven Clinical Diagnostics, Physician Recommendations, and Prescription Medications to Help People Live Healthier Lives.
Plans are announced to hire new talent across its design and engineering, information technology, project management, and software development teams.
COVID-19 testing revenues increase by automating claim submissions for over 8,700 insurance carriers and respective government agencies.
Medivolve closes $12M in funding needed to support strategic plan including next phase of growth for AI technology platform that will change the face of human health management.
Medivolve announces private placement offering of units to be used for pursuing investment opportunities, marketing, and for general corporate purposes.
Marbella Pharmacy has received its initial allocation of the Johnson & Johnson vaccine.
https://www.youtube.com/watch?v=OdeIK-BSuII
New Brand Supports Strategic Corporate Vision as “One Medivolve” Built for Transformation; Solidifying Mission to Address Gaps in the Nation’s Health System
Developers worked to create new technology known as BlowFISH to detect the presence of the virus through directly testing respiratory droplets. WCNC – TV – NBC
The technology has entered the next phase toward applying for an EUA from the FDA to test for the COVID-19 virus. Medical Product Outsourcing
New platform supports Medivolve’s position as a growing health technology and services company
Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow.
https://www.youtube.com/watch?v=STjOgDQMlLo
Toronto, Ontario May 6, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to transform human health management, today announces that a webinar will be held on Tuesday, May 11th at 11 am ET. The webinar will feature newly appointed Medivolve CEO, David Preiner…
New platform supports Medivolve’s position as a growing health technology and services company
Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic technology that has cleared the first milestone in a series of clinical tests and has entered the next phase toward applying for an Emergency Use Authorization from the…
Toronto, Ontario April 30, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare investment management company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to help combat COVID-19, today announced that David Preiner has been appointed Chief Executive Officer (CEO), effective immediately. Preiner will succeed Doug Sommerville, who will assist as a transitionary…
Toronto, Ontario April 15th, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce it is hosting a Corporate Update webinar, on Thursday, April 15th at 1 pm ET that will provide investors with an update on the Company’s recent business developments. Registration Link: https://us02web.zoom.us/webinar/register/WN_pRyhGijjSgCGKKsE90lMPQ Specifically, the webinar will feature Medivolve CEO Doug Sommerville as…
Test Kits from Collection Sites to be sold in convenience stores and big-box retailers across the United States, expanding on its mission to bring convenient, fast and reliable COVID-19 testing to more homes, schools and businesses
Medivolve announces an investor webinar Thursday April 15th at 1 pm ET.
Toronto, Ontario April 1, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer AditxtScore™ for COVID-19 through its mobile testing centres. Aditx Therapeutics (Nasdaq: ADTX), is a biotech innovation company focused on improving the health of the immune system. Collection Sites, LLC provides testing…
As part of the Government funded HRSA program, Collection Sites will be able to offer uninsured and undocumented patients with access to free PCR tests.
Collection Sites launched mutli-week custom testing solutions for a high-school athletics department in Redland, California and a film production company in Los Angeles as part of its new business-focused sales strategy. Further, Medivolve announces an investor webinar Tuesday, March 23th at 1 pm ET
https://www.youtube.com/watch?v=-Iv-FZ7kovE
https://www.youtube.com/watch?v=Yak_h05G4eQ
As part of its telehealth strategy, Medivolve has acquired a pharmacy to better serve Collection Sites telehealth patients as the program launches. Further, Medivolve will host an investor webinar Tuesday, March 23rd at 1 pm ET
Toronto, Ontario, March 2, 2021 — Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) announces the launch of an operating model with Besser Brands in the state of Florida. Under this framework Besser Brands is initially operating 9 Collection Sites locationsunder the Collection Sites branding, where they are responsible for all related operating costs and systems…
Medivolve will host a webinar Monday, February 22nd at 1 pm ET with medical advisor Dr. Glenn Copeland to discuss Collection Sites telehealth strategy.
After successful operational results from its Collection Sites subsidiary, which includes the sale of 73,973 tests at an average price of $96 in January, Medivolve is initiating an investor awareness campaign.
Medivolve will host a webinar Monday, February 22nd at 1 pm ET with medical advisor Dr. Glenn Copeland to discuss Collection Sites telehealth strategy. Further, Tim Shelburn is stepping down from his executive role at Collection Sites.
Medivolve Also Strengthens its Balance Sheet via Shares for Debt Settlements.
To date Collection Sites has launched a total of 62 sites across its network with additional new openings in Texas, Florida, and North Carolina. Further, Medivolve will host a webinar today, Thursday, February 4th at 1 pm ET.
Nuturell’s non-toxic silver surface shield technology is a COVID-19 disinfectant that convertsinto a protective shield when air dry, killing the coronavirus among other pathogens for up to 90 days after only ~30 seconds of contact. Further, Medivolve will host a webinar Thursday, February 4 th at 1 pm ET.
Medivolve will host a webinar Thursday, February 4th at 1 pm ET. This includes an overview of Collection Sites’ network growth and a presentation from the UCLA researchers behind the Marvel Diagnostics innovative BlowFISH Technology for the detection of the presence of the COVID-19 virus.
Marvel Diagnostics innovative BlowFISH technology offers the potential for a a simple,
inexpensive, non-invasive, massively-deployable, rapid diagnostic or sentinel system for detecting respiratory illness and airborne viral threats.
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO – January 25, 2021 (GLOBE NEWSWIRE) Medivolve, Inc. (“Medivolve”)
(NEO:MEDV; OTC:COPRF; FRA:4NC) released a statement on the passing of its strategic
advisor, Larry King. With great sadness, we honor the death of our advisor and friend.
Collection Sites and Celebrity Heidi Powell Opens Two Covid-19 Testing Centers – Gives Away Free 30-day Subscription to The Transform App and Provides Access to Innovative Fitness and Nutrition Content to Help People Strengthen and Maintain Healthy Bodies
The continued success of Collection Sites rollout has led to the expansion into Pennsylvania, with 5 sites now operating across the state for a total of 40 operating sites.
The continued success of Collection Sites rollout has led to the expansion into Pennsylvania, with 5 sites now operating across the state for a total of 40 operating sites.
Through a partnership with the the Town of East Hampton, Collection Sites opens testing centre at the town’s Town Hall Campus, completing expansion into New York.
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
QuestCap supplied Kinross Gold subsidiary with RT-PCR and antibody COVID-19 tests, analyzers and associated testing protocols for complete COVID-19 testing solution.
The success of Collection Sites national rollout has led to the expansion into New York, with the site expected to be operational by January 6th.
The 33 new Tanger Outlet sites add to Collection Sites total potential network of over 700 contracted sites, with each site capable of 150 tests per day at a demonstrated average price of US$85 per test.
The 33 new Tanger Outlet sites add to Collection Sites total potential network of over 700 contracted sites, with each site capable of 150 tests per day at a demonstrated average price of US$85 per test.
The 33 new Tanger Outlet sites add to Collection Sites total potential network of over 700 contracted sites, with each site capable of 150 tests per day at a demonstrated average price of US$85 per test.
With 20 sites operational and 25 more sites expected to be operational before Christmas, Collection Sites is poised to capitalize on an expected holiday testing surge.
Toronto, Ontario December 3rd, 2020 — QuestCap Inc. (“QuestCap”) (CSE:QSC; FRA:34C1) is pleased to announce the inclusion of partner company Glenco Medical’s Standard for Safe Sport with the NBA’s Houston Rockets training camp for the 2020-2021 NBA season. This implementation includes the sale of 1,024 rapid antigen tests and 120 antibody tests to the Houston Rockets. Houston…
Toronto, Ontario December 1, 2020 — QuestCap Inc. (“QuestCap”) (NEO:QSC; OTC:COPRF; FRA:34C1) is pleased to announce strong initial test sales at its wholly owned subsidiary, Collection Sites, LLC. Highlights Include: Surging test sales amid recent Collection Sites media coverage and increasing COVID-19 cases across the United States. Demand for Collection Sites unique value-proposition of convenient and effective…
Toronto, Ontario November 18, 2020 — QuestCap Inc. (“QuestCap”) (NEO:QSC; OTC:COPRF; FRA:34C1) is pleased to announce the launch of a master license agreement between its wholly owned subsidiary, Collection Sites, LLC and Brixmor Property Group (NYSE: BRX), a real estate investment trust (REIT) that owns and operates a high-quality, national portfolio of open-air shopping centers with retailers…
Toronto, Ontario – November 17, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (NEO:QSC; OTC:COPRF; FRA:34C1), is pleased to announce that it has initated the process to change its corporate name to Medi-Volve in conjunction with its transition to a single purpose medical company, previously announced on October 13th, 2020. This name change is intended to emphasize…
Toronto, Ontario November 11, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (NEO:QSC; OTC:COPRF; FRA:34C1), through its wholly-owned subsidiary, Collection Sites, LLC has signed a binding letter of intent with Elf Attractions LLC, the producer of The Elf on the Shelf’s Magical Holiday Journey, to implement COVID-19 testing protocols for event employees. Elf Attractions LLC, a joint…
Toronto, Ontario October 26, 2020 — QuestCap Inc. (“QuestCap”) (NEO:QSC; OTC:COPRF; FRA:34C1) is pleased to announce the launch of an agreement between its wholly owned subsidiary, Collection Sites, LLC and BPR REIT Services LLC (“Brookfield Properties”), a subsidiary of global real estate company Brookfield Property Partners, listed on the NASDAQ (NASDAQ:BPY). Collection Sites will lease 50 x…
TORONTO, Oct. 21, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap”) (NEO:QSC; OTC:COPRF; FRA:34C1) is pleased to announce the launch of an agreement between its wholly owned subsidiary, Collection Sites, LLC and Sandor Development Company (“Sandor”), one of the largest privately-held shopping center developers with locations across the United States which often adjoin such retail giants as Home Depot, Walmart,…
Toronto, Ontario October 13, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce that it will be uplisting to the NEO Exchange (“NEO”) effective October 15, 2020, concurrent with the NEO listing, the Company will transition to a single purpose company from an investment issuer, redeploying its assets and resources to be…
Collection Sites has signed lease agreements for the first 15 locations, with plans to open additional COVID-19 testing locations with H&S Energy, LLC.
Toronto, Ontario September 22, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) through its wholly-owned subsidiary, Collection Sites, LLC is working with Art Angels Gallery, Los Angeles, California to launch COVID-19 testing protocols to help safely return art exhibitions for artists and consumers. This event will feature world-renown artist Russell Young September 24th, 2020 in…